Literature DB >> 11222652

Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

D T Winkler1, L Bondolfi, M C Herzig, L Jann, M E Calhoun, K H Wiederhold, M Tolnay, M Staufenbiel, M Jucker.   

Abstract

A high risk factor for spontaneous and often fatal lobar hemorrhage is cerebral amyloid angiopathy (CAA). We now report that CAA in an amyloid precursor protein transgenic mouse model (APP23 mice) leads to a loss of vascular smooth muscle cells, aneurysmal vasodilatation, and in rare cases, vessel obliteration and severe vasculitis. This weakening of the vessel wall is followed by rupture and bleedings that range from multiple, recurrent microhemorrhages to large hematomas. Our results demonstrate that, in APP transgenic mice, the extracellular deposition of neuron-derived beta-amyloid in the vessel wall is the cause of vessel wall disruption, which eventually leads to parenchymal hemorrhage. This first mouse model of CAA-associated hemorrhagic stroke will now allow development of diagnostic and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222652      PMCID: PMC6762950     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  66 in total

1.  Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice.

Authors:  A L Phinney; T Deller; M Stalder; M E Calhoun; M Frotscher; B Sommer; M Staufenbiel; M Jucker
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 2.  Cerebral amyloid angiopathy: an overview.

Authors:  M Yamada
Journal:  Neuropathology       Date:  2000-03       Impact factor: 1.906

3.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; T A Newman; M Hutchings; Y M Kuo; A E Roher
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy.

Authors:  S M Greenberg; H C O'Donnell; P W Schaefer; E Kraft
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

5.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

6.  Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.

Authors:  R Vidal; M Calero; P Piccardo; M R Farlow; F W Unverzagt; E Méndez; A Jiménez-Huete; R Beavis; G Gallo; E Gomez-Tortosa; J Ghiso; B T Hyman; B Frangione; B Ghetti
Journal:  Acta Neuropathol       Date:  2000-07       Impact factor: 17.088

7.  Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases.

Authors:  H Barelli; A Lebeau; J Vizzavona; P Delaere; N Chevallier; C Drouot; P Marambaud; K Ancolio; J D Buxbaum; O Khorkova; J Heroux; S Sahasrabudhe; J Martinez; J M Warter; M Mohr; F Checler
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

8.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

Authors:  J P Vonsattel; R H Myers; E T Hedley-Whyte; A H Ropper; E D Bird; E P Richardson
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

Review 9.  Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment.

Authors:  S M Greenberg
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  Beta-amyloid formation by myocytes of leptomeningeal vessels.

Authors:  H M Wisniewski; J Wegiel
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  91 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 3.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

4.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

5.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

Authors:  Veronica Lifshitz; Ronen Weiss; Tali Benromano; Einat Kfir; Tamar Blumenfeld-Katzir; Catherine Tempel-Brami; Yaniv Assaf; Weiming Xia; Tony Wyss-Coray; Howard L Weiner; Dan Frenkel
Journal:  Neurobiol Aging       Date:  2011-03-02       Impact factor: 4.673

Review 6.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

7.  Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.

Authors:  Laibaik Park; Joan Zhou; Ping Zhou; Rose Pistick; Sleiman El Jamal; Linda Younkin; Joseph Pierce; Andrea Arreguin; Josef Anrather; Steven G Younkin; George A Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 8.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

9.  Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Authors:  Thomas Mueggler; Christine Sturchler-Pierrat; Diana Baumann; Martin Rausch; Matthias Staufenbiel; Markus Rudin
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 10.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.